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Koos, Brian J., Yoshikazu Kawasaki, Young-Han Kim, and
Fanor Bohorquez. Adenosine A2A-receptor blockade abolishes the
roll-off respiratory response to hypoxia in awake lambs. Am J Physiol
Regul Integr Comp Physiol 288: R1185–R1194, 2005. First published
December 23, 2004; doi:10.1152/ajpregu.00723.2004.—Adenosine
(ADO) receptor antagonists (aminophylline, caffeine) blunt the respi-
ratory roll-off response to hypoxia in the newborn. This study was
designed to determine the ADO receptor subtype involved in the
respiratory depression. Chronically catheterized lambs of 7–16 days
of age breathed via face mask a gas mixture with a fraction of inspired
O2 of 0.21 (normoxia) or 0.07 (hypoxia), while being infused intra-
vascularly with 9-cyclopentyl-1,3-dipropylxanthine (DPCPX; ADO
A1-receptor antagonist, n  8), ZM-241385 (ADO A2A-receptor
antagonist, n  7), or vehicle. Ventilation was measured at 20°C by
a turbine transducer flowmeter. In normoxia [arterial PO2 (PaO2) of
83 Torr], infusion of vehicle did not alter cardiorespiratory mea-
surements, whereas hypoxia (PaO2 of 31 Torr, 15 min) elicited
biphasic effects on mean arterial pressure (transient increase), heart
rate (HR; diminishing tachycardia), and minute ventilation. In the
latter, hypoxia increased ventilation to a peak value of 2.5 times
control within the first 3 min, which was followed by a significant
(P  0.05) decline to 50% of the maximum increment over the
subsequent 7 min. ZM-241385 abolished the hypoxic ventilatory
roll-off and blunted the rate of rise in HR without affecting mean
arterial pressure or rectal temperature responses. In normoxia,
DPCPX increased ventilation and mean arterial pressure but did not
change HR. Compared with vehicle, DPCPX did not significantly
affect cardiorespiratory responses to hypoxemia (PaO2 of 31 Torr,
10 min). It is concluded that 1) ADO A2A receptors are critically
involved in the ventilatory roll-off and HR responses to hypoxia, and
2) ADO A1 receptors, which are tonically active in cardiorespiratory
control in normoxia, appear to have little impact on hypoxic ventila-
tory depression.
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THE RESPIRATORY RESPONSE of the human newborn to hypoxia is
biphasic: an initial stimulation followed by a decline toward
control levels (3, 34). The hyperpnea is blunted in preterm
infants and, in fact, is not evident during sleep in those
weighing 1,500 g (1). The depression of ventilation in the
second phase, which is more prominent in developmentally
immature newborns (e.g., kittens, human neonates), is attenu-
ated with greater neurological maturity, as in newborn lambs
(7). A second-phase ventilatory decline can also be observed in
conscious cats (40), goats (14), and human subjects (13), but
adults of most other species display the roll-off only while
anesthetized. Thus the magnitude of the reduction in ventila-
tion in the second phase depends on the state of consciousness,
species, maturity, and degree of hypoxia (2, 3).
Low PO2 levels in the brain trigger the decline in ventilation,
which may be accompanied by impaired integration of afferent
input from the carotid sinus nerves into respiratory drive (3).
Most evidence indicates that a time-dependent attenuation in
peripheral arterial chemoreceptor activity is not involved. Re-
duced metabolic rate and other factors can also contribute to
the respiratory roll-off (3, 34).
A rise in brain concentrations of adenosine may have a
critical role in the second-phase response because the roll-off is
generally attenuated by adenosine receptor blockade achieved
with methylxanthines, such as aminophylline and caffeine.
This blunting of the depressant phase has been demonstrated in
anesthetized rabbit pups (35), piglets (10), and adult rats (39).
Adenosine receptor antagonists have also reduced the ventila-
tory roll-off in conscious cats (28) and human subjects (13).
Central application of stable agonists highly selective for
adenosine A1 receptors depressed respiration in decerebrate
rabbit pups and anesthetized rats and cats, a response that was
blocked by nonselective adenosine receptor antagonists. Thus,
of the four adenosine receptors (A1, A2A, A2B, A3), the aden-
osine A1 receptor has been surmised to be the key subtype
involved in hypoxic respiratory inhibition (3).
In unanesthetized fetal sheep (3), intravascular infusion of
methylxanthines that effectively cross the blood-brain barrier
also blunts the depressant effects of hypoxia on breathing
movements (4, 7, 21, 26), and stable adenosine A1-receptor
agonists, injected intravenously or into the cisterna magna,
inhibit breathing activity. These observations are consistent
with the notion that adenosine A1 receptors also mediate the
hypoxic arrest of fetal breathing. Subsequent studies with an
adenosine A2A-receptor agonist and more potent, specific, and
selective adenosine receptor antagonists, however, have shown
that adenosine A2A receptors (rather than A1) are critically
involved in hypoxic inhibition of fetal breathing (20, 25).
These provocative results raise the question as to whether
central adenosine A2A receptors also depress respiratory re-
sponses to hypoxia in postnatal life. In this study, highly
selective antagonists to adenosine A1 and A2A receptors were
administered to developing lambs to determine whether they
would blunt the second-phase decline in ventilation. These
experiments were designed to test the hypothesis that the
adenosine A2A-receptor subtype is involved in the hypoxia-
induced ventilatory roll-off in newborn lambs, as it is in the
fetus.
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EXPERIMENTAL PROCEDURES
All surgical and experimental procedures were carried out in
accordance with the guidelines of the American Physiological Society
and were approved by the UCLA Chancellor’s Animal Research
Committee. Upon completion of the studies, euthanasia of the lambs
was achieved by intravenous injection of pentobarbital sodium (180
mg/kg iv).
Surgery
Fifteen lambs 3–5 days of age underwent aseptic surgery for
placement of vascular catheters. Oxytetracycline (10 mg/kg), ampi-
cillin (20 mg/kg), and atropine (0.1 mg/kg) were administered intra-
muscularly about 30 min before induction of 0.5% isoflurane anes-
thesia; buprenorphine (0.01 mg/kg im) and ketamine (3 mg/kg iv)
were injected before intubation for general anesthesia. Polyvinyl
catheters, which were implanted in the right external jugular vein and
carotid artery, were advanced so that the catheter tips were within the
superior vena cava and aorta, respectively. The catheters were exte-
riorized through a small incision on the right dorsolateral thorax and
secured in a nylon pouch attached to the lamb’s flank.
After recovery from anesthesia, the lambs were housed with their
ewes. Lamb weights were measured daily to document normal weight
gain (0.3 kg/day). The catheters were kept patent by daily injections
of heparinized saline (4 U/ml).
Experiments
Studies in lambs (7–16 days of age) were begun at least 2 days after
surgery at the lower range of thermoneutrality (20°C), an ambient
temperature that maintains body temperature in normoxia with min-
imal O2 consumption (38). The unanesthetized lamb was placed in the
prone position in a sling. Arterial pressure, which was measured with
a pressure transducer (Argon Medical, Dallas, TX) and amplifier
(Quadbridge amplifier, ADInstruments, Mountain View, CA), was
referenced to the level of the right atrium. Heart rate was determined
from the arterial pressure pulse. Arterial PO2 (PaO2), PCO2 (PaCO2), and
pH were measured on a blood-gas machine (Instrumentation Labora-
tories, Lexington, MA) with measurements corrected to 39°C. Rectal
temperature was measured with a Thermalert model TH-8 tempera-
ture probe (Physitemp, Clifton, NJ).
Ventilation was measured by a precision turbine transducer flow-
meter (Interface Associates, Laguna Nigel, CA), which was attached
to a malleable rubber face mask (Jorgensen Laboratories, Loveland,
CO) that was bonded with hydrophilic vinyl polysiloxane (31) to the
lamb’s shaven snout. The analog-output signal was processed with an
electronic ventilation measurement module (VMM-400, Interface
Associates) to record the increment in lung volume over the time of
each inspiration. The signal was reset to zero after peak inspiratory
volume (i.e., tidal volume) was achieved. Breath interval was calcu-
lated from the time of the start of each breath. This volume transducer
had a resolution of 0.5 ml and a linear accuracy of1.5% for volumes
up to 3 l/s. The turbine transducer flowmeter had the advantages of
stability of calibration and of no zero drift.
Gas mass flowmeters (302 series, Hastings Instruments, Hampton,
VA) and a controller (model 400, Hastings Instruments) provided
precision mixing of respiratory gases (air, O2, CO2, and N2). The
humidified gas mixture flowed (18 l/min) through flexible respiratory
tubing (2.2 cm ID) that was attached via a Y-connector to the
flowmeter and face mask. End-tidal O2 fraction was measured (model
175818 oxygen analyzer, VacuMed, Ventura, CA) continuously from
gas drawn from the face mask.
Heart rate, arterial pressure, rectal temperature, and respiratory
volumes were sampled at 200 Hz, displayed on an electronic chart
recorder (PowerLab/16 SP chart data recorder, ADInstruments), and
recorded on the hard drive of a microcomputer.
Experimental protocol. The lambs breathed air from the respiratory
circuit for at least 15 min before the onset of hypoxia (fraction of
inspired O2  0.07). An intravenous infusion of a selective adenosine
receptor antagonist or its vehicle was started 10 min before induction
of hypoxia. A total of 30 ml of each solution (at 20°C, room
temperature) was infused for each experiment. One experiment was
performed per day to minimize potential carryover effects of the
adenosine receptor antagonists, and the order of infusion (drug,
vehicle) was varied to control for order and/or time effects (25).
Arterial blood-gas and pH levels were measured before infusion
(control) and 1, 5, 10, and 15 min after the start of hypoxia. A
recovery sample was taken 10 min after inspired O2 fraction was
restored to normal. Carbon dioxide (0.2–0.8 l/min) was added to the
hypoxic gas mixture to minimize changes in PaCO2 that could con-
found interpretation of results (32). Adjustments in inspired CO2
fraction were made according to measured PaCO2.
Adenosine A1-receptor antagonist. 9-Cyclopentyl-1,3-dipropylxan-
thine (DPCPX; Tocris Cookson, Ballwin, MO) was dissolved in 0.04
M 2-hydroxypropyl--cyclodextrin and 0.2 N NaOH (50:50, vol/vol)
to a final drug concentration of 2.5 mg/ml. DPCPX was infused into
the superior vena cava at 1.2 mg min1 kg1 over 10 min of
normoxia and, subsequently, at 0.24 mg min1 kg1 for 15 min of
hypoxia. During these studies, the duration of hypoxia was reduced
from 15 to 10 min because lambs with adenosine A1-receptor block-
ade were less tolerant of low PaO2. The dose of this highly specific and
selective adenosine A1-receptor antagonist was based on our previous
studies in fetal sheep (25). The extent of adenosine A1-receptor
blockade was determined by respiratory responses to hypoxia upon
doubling the dose of DPCPX.
Adenosine A2A-receptor antagonist. ZM-241385 (Tocris Cookson)
was dissolved in polyethylene glycol at 400 and 0.1 N NaOH (50:50,
vol/vol) and diluted with saline to a final concentration of 0.66 mg/ml.
ZM-241385 was infused into the superior vena cava at 0.65
mg min1 kg1 for 10 min of normoxia and 0.056 mg min1 kg1
for 15 min of hypoxia. The dose of ZM-241385, a highly specific and
selective blocker of adenosine A2A receptors, was based on our
previous work in fetal sheep (25). The adequacy of adenosine receptor
blockade was determined by evaluating respiratory responses to
hypoxia while administering twice the dose of the antagonist.
Data Analysis Methods
Mean values of heart rate, mean arterial pressure (MAP), temper-
ature, tidal volume, inspiratory time (TI), and respiratory period (total
breath duration or TTOT) were determined for sequential 20-s epochs
with the use of PowerLab software (ADInstruments). Minute venti-
lation (l min1 kg1) was calculated by multiplying tidal volume
(l/kg) by 60 s/min with division of this value by respiratory period
(s/breath). Measurements before the start of infusion were subtracted
from values during the infusion and recovery to correct for baseline
differences. These mean profiles over time were compared within and
between groups using a two-way repeated-measures ANOVA model
and the Tukey-Fisher’s least significant difference post hoc compar-
ison criterion (JMP version 5.1, SAS Institute, Cary, NC). The two
fixed factors in the two-way repeated-measures analysis were time
and infusion group (infusion of drug or vehicle).
Minute ventilation was also analyzed by phase, in which phase 1
was defined as the maximum ventilation for each lamb achieved
during the first 5 min of hypoxia and phase 2 or roll-off was defined
as ventilation measured 10 and 15 min after the start of hypoxia.
Ventilation was compared within and between groups by an ANOVA
model and the Tukey-Fisher’s least significant difference post hoc
comparison criterion. Phase and the infusion group were the two fixed
factors in the two-way repeated measures analysis.
For selected time periods of infusion (normoxia, hypoxia), slopes
(rates) of temperature change for normoxia and hypoxia were deter-
mined for each animal by linear regression, and the mean slopes for
ZM-241385, DPCPX, and vehicle were compared within and between
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animals by two-way repeated measures ANOVA, where time period
(not time in min) and drug were the fixed factors. Differences were
considered statistically significant if P  0.05. Values given are
means  SE.
RESULTS
Adenosine A1-Receptor Blockade
DPCPX was infused intra-arterially to eight lambs at 10.1
0.8 (DPCPX) and 10.4 0.9 (vehicle) days of age. Mean lamb
weights were 6.82  0.49 and 6.87  0.52 kg for DPCPX and
vehicle experiments, respectively. In these experiments, the
duration of hypoxia was shortened from 15 to 10 min because
the DPCPX-treated lambs were less tolerant of acute falls in
PaO2.
Arterial blood gases and pH. DPCPX minimally affected
blood gases and pH in normoxic lambs (n  3). Before
infusion, mean PaO2, PaCO2, and pH were 92.7  0.6 Torr,
41.1  1.7 Torr, and 7.438  0.040, respectively. DPCPX
infusion (8 min) was associated with a PaO2 of 96.6  2.1
Torr, a PaCO2 of 39.3 1.8 Torr, and an arterial pH of 7.454
0.011. Infusion of the vehicle had virtually no effect on PaO2(preinfusion: 88.8  5.5 Torr, infusion: 86.0  6.7 Torr),
PaCO2 (preinfusion: 41.4 0.9, infusion: 41.9 0.9 Torr), and
pH (preinfusion: 7.428  0.029, infusion: 7.439  0.027).
During hypoxia, PaO2 was lowered to 30–33 Torr, whereas
mean PaCO2 was kept within 2–4 Torr of control (Fig. 1A).
Hypoxia significantly decreased arterial pH only in lambs
treated with the adenosine A1-receptor blocker.
Cardiovascular responses. In control vehicle experiments
(n  7), hypoxia increased MAP by 7 mmHg (P  0.07),
which was followed by a decline toward control levels (Fig.
2A). In contrast, DPCPX was associated with a progressive
increase in MAP in normoxia that was further enhanced by7
mmHg (P  0.07) within the first minute of hypoxia before
falling back toward control values.
In vehicle-treated lambs, mean heart rate rapidly increased
within 3 min of the onset of hypoxia, which was followed by
a progressive decline from maximum rates during the last 6
min of hypoxia. Heart rate responses to hypoxia in DPCPX-
treated lambs were similar except that the tachycardia persisted
throughout the 10-min recovery period.
Temperature. Mean rectal temperatures under basal condi-
tions before the start of infusion were 39.99  0.10 and
40.12  0.09°C, respectively, for DPCPX and vehicle exper-
iments (n  6). Mean rectal temperature declined by 0.022 
0.006°C/min during the 10-min vehicle infusion before hyp-
oxia (n  4), which was not significantly different from the
0.01  0.006°C/min reduction with DPCPX. The tempera-
ture in vehicle-treated lambs continued to fall at the same rate
(0.017  0.006°C/min) during hypoxia (Fig. 2A).
Two distinctly different responses in core temperature oc-
curred in lambs treated with DPCPX and hypoxia. In the first,
Fig. 1. Effects of hypoxia on arterial blood gases and pH.
A: intravenous infusion of 9-cyclopentyl-1,3-dipropylxan-
thine (DPCPX; F) or vehicle (E) in 8 lambs. B: intravenous
administration of ZM-241385 (F) or vehicle (E) in 7 lambs.
*P  0.05 compared with 0 min. †P  0.05 compared with
vehicle at same time.
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mean core temperature did not fall with hypoxia in four lambs
(8–13 days of age), which resulted in rectal temperatures
significantly greater than vehicle-treated lambs during virtually
the entire 10 min of hypoxia (Fig. 2A). In these DPCPX-treated
lambs, the slope of the change in rectal temperature as a function
of time for hypoxia (0.011  0.006°C/min) was significantly
greater than for normoxia. In the second, mean rectal temper-
ature in two lambs (7 and 9 days of age) declined by 0.049°C/
min during hypoxia with DPCPX infusion (Fig. 2A, bottom).
Inspiratory time. In vehicle studies, TI was unaltered by
normoxia but was reduced by nearly 40% by hypoxia (Fig. 3A).
In DPCPX-treated lambs, TI progressively fell in normoxia but
was not decreased further by hypoxia. During recovery, TI
remained decreased in DPCPX-treated lambs compared with
vehicle-infused animals.
Respiratory period. In control vehicle studies, TTOT, which
was unaltered by normoxia, was reduced nearly 50% by
hypoxia, with a subsequent return to control values upon
normalization of fetal PaO2. DPCPX lowered TTOT in nor-
moxia, an effect that persisted in hypoxia and recovery.
Tidal volume. In normoxia, DPCPX administration was
associated with an30% rise in tidal volume that did not reach
statistical significance (P  0.08) with the number of animals
studied. Hypoxia rapidly increased tidal volume by more than
two-fold, which was followed by a gradual decline over the
remainder of hypoxia.
Fig. 2. Changes () in mean arterial pres-
sure (MAP), heart rate (HR), and rectal tem-
perature (TR). A: administration of adenosine
A1-receptor blocker DPCPX (F) or vehicle
(E) in 7 (MAP, HR) and 6 lambs (TR). Panel
3 shows changes in rectal temperature in 4
lambs, and bottom panel depicts results in 2
additional lambs [no. 301 (circles), no. 351
(triangles)] that had atypical temperature re-
sponses to hypoxia with DPCPX infusion. B:
infusion of adenosine A2A-receptor blocker
ZM-241385 (F) or vehicle (E) in 5 lambs.
*P 0.05 compared with 10 min. †P 0.05
compared with vehicle. {P  0.05 for nor-
moxia measurements compared with time 0.
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Minute ventilation. Vehicle-treated lambs displayed a clear
biphasic respiratory response to hypoxia. Ventilation, which
was unchanged in normoxia, rose nearly four-fold within 2 min
of the start of hypoxia but subsequently fell (P  0.05) to
60% of the peak increment by the end of hypoxia.
DPCPX significantly increased minute ventilation by over
two-fold in normoxia. Because of this change in baseline,
ventilation reached significantly higher levels than those
achieved in control vehicle experiments. Doubling the dose of
DPCPX did not alter the respiratory response.
Baseline shifts in DPCPX-treated lambs have been taken
into account in Fig. 4, which shows changes in respiratory
variables in hypoxia relative to measurements taken immedi-
ately before hypoxia. In this analysis, the maximum stimula-
tory response to hypoxia in DPCPX-treated lambs appears
blunted compared with vehicle-treated lambs, although the
difference was not significant (P  0.08) with the number of
lambs studied. Otherwise, ventilatory responses were virtually
identical for vehicle- and DPCPX-treated animals.
Ventilatory responses to hypoxia according to phase are
shown in Fig. 5A. In vehicle-treated lambs, ventilation mea-
sured 10 min after the start of hypoxia was 37% lower (P 
0.004) compared with peak phase 1 values (top) or 46% lower
(P  0.001) than the phase 1 increment (bottom). This venti-
latory roll-off was not significantly altered by DPCPX.
Adenosine A2A-Receptor Blockade
Respiratory responses to ZM-241385 and hypoxia were
determined in seven lambs at 10.9  0.7 (ZM-241385) and
10.3  0.8 (vehicle) days of age. Mean weights of the lambs
were 6.29  0.57 and 6.30  0.61 kg for experiments involv-
ing ZM-241385 and vehicle, respectively.
Arterial blood gases and pH. During hypoxia, mean PaO2
was reduced to 31 Torr from the control of 83 Torr (Fig.
1B). Hypoxia was associated with relatively small changes in
PaCO2 (3 Torr) with significantly lower values in the first 5
min of hypoxia in the group that received the adenosine
A2A-receptor antagonist. For both vehicle and ZM-241385
experiments, mean arterial pH was not significantly reduced
until 10 min after hypoxia was terminated.
Cardiovascular responses. A transient increase (P  0.06)
in MAP of 5–6 mmHg occurred within the first 2 min of
hypoxia in lambs treated with either vehicle or ZM-241385
Fig. 3. Effects of selective antagonism of
adenosine A1- or A2A-receptor subtypes on
inspiratory time (TI), respiratory period, tidal
volume, and minute ventilation. A: DPCPX
(F) or vehicle (E) in 8 lambs. B: ZM-241385
(F) or vehicle (E) in 7 lambs. {P  0.05 for
normoxia measurements compared with time
0. *P  0.05 compared with 10 min. †P 
0.05 compared with vehicle. P 0.05 com-
pared with peak minute ventilation at 12–13
min.
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(Fig. 2B). In both groups, MAP fell after 2 min, which became
significantly less than prehypoxic values for the vehicle group
after 12 min of hypoxia.
In vehicle-treated lambs, hypoxia induced a tachycardia,
which declined over the last 5 min of hypoxia. ZM-241385
significantly blunted the hypoxia-induced rise in heart rate;
however, the maximum rate, which was similar in magnitude
to vehicle, was sustained throughout latter stages of hypoxia.
Temperature. Mean rectal temperatures under basal condi-
tions before the start of infusion were 39.83  0.17 and
39.64  0.12°C for lambs treated with ZM-241385 and vehi-
cle, respectively. In normoxia, the decline in rectal temperature
(n  5) was similar for vehicle- and ZM-241385-treated lambs
(slope: 0.017  0.004°C/min for vehicle, 0.013 
0.004°C/min for ZM-241385). The slopes of temperature fall
during hypoxia, which were 0.015  0.004°C/min for vehi-
cle and0.015 0.004°C/min for ZM-241385, were virtually
identical to those for normoxia. In both cases, rectal tempera-
Fig. 5. A, top: effects of DPCPX or vehicle on maximum hypoxic stimulation
of ventilation (phase 1) in each lamb and on ventilation 10 min (roll-off10) and
15 min (roll-off15) after the start of hypoxia. Bottom: changes in ventilation
from control for phase 1 and for roll-off10 and roll-off15. B, top: effects of
ZM-241385 or vehicle on the maximum stimulatory effects of hypoxia on
ventilation (phase 1) in each lamb and at roll-off10 and roll-off15. Bottom:
changes in ventilation from control for phase 1 and for roll-off10 and roll-off15.
*P  0.05 compared with control. †P  0.05 compared with vehicle. P 
0.05 compared with phase 1.
Fig. 4. Changes in TI, respiratory period, tidal volume, and minute ventilation
during hypoxia with intravenous infusion of DPCPX (F) or vehicle (E). *P 
0.05 compared with time 0. †P  0.05 compared with vehicle. P  0.05
compared with peak ventilation at 2 min for vehicle infusions.
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ture rose toward control values on termination of the infusion
and hypoxia.
Inspiratory time. TI, which was not altered by infusion of
ZM-241385 or vehicle in normoxia, was significantly reduced
by hypoxia in both cases (Fig. 3B). TI increased rapidly after
PaO2 was returned to normal, with the initial recovery value
significantly greater than that at time 0. The effects of adeno-
sine A2A-receptor blockade with hypoxia on TI were similar to
those observed for vehicle.
Respiratory period. The adenosine A2A-receptor antagonist
did not significantly alter TTOT in normoxic lambs (Fig. 3B).
Hypoxia reduced mean TTOT by about one-third, which approx-
imated the response observed with the vehicle alone.
Tidal volume. In vehicle-treated lambs, the hypoxia-induced
rise in tidal volume was not sustained as ventilation fell over
the last 10 min of hypoxia. In ZM-241385 experiments, tidal
volume rose within the first minute of hypoxia, an increment
that was either maintained or augmented through the remainder
of hypoxia.
Minute ventilation. Neither the vehicle nor ZM-241385
changed minute ventilation in normoxia. Vehicle-treated lambs
displayed a biphasic respiratory response to hypoxia that was
characterized by an initial 2.3-fold rise in ventilation followed
by 50% retracement from peak values. ZM-241385 abol-
ished the depressant response: the initial 2.6-fold rise in ven-
tilation was sustained or augmented throughout the 15 min of
hypoxia. Doubling the dose of ZM-241385 did not signifi-
cantly alter the monophasic respiratory response.
Analysis according to phase response (phase 1 and roll-off
responses 10 and 15 min after the start of hypoxia) revealed
that, in vehicle-treated lambs, ventilation measured 10 or 15
min after the start of hypoxia was 37% less (P  0.002) than
the maximum value of phase 1 (Fig. 5B, top). Relative to
control, maximum phase 1 ventilation was increased by 1
l min1 kg1, which was followed by a 60% decline (P 
0.002) for ventilation measured 10 and 15 min after the start of
hypoxia (Fig. 5B, bottom). In contrast, ventilation was main-
tained throughout the 15 min of hypoxia in lambs treated with
ZM-241385.
DISCUSSION
This study shows that activation of adenosine A2A receptors
mediates the respiratory roll-off response to hypoxia in lambs;
adenosine A1 receptors do not appear to be significantly in-
volved. That adenosine A2A receptors are crucial modulators of
the depressant respiratory effects of hypoxia in the fetal sheep
(25) and developing lambs indicates that a central adenosiner-
gic inhibitory pathway remains functional as respiratory con-
trol changes at birth.
Hypoxia-Induced Responses During Vehicle Infusion
Cardiorespiratory and temperature changes to vehicle infu-
sion were measured to establish control responses to normoxia
and hypoxia. These experiments were used to compare lamb
responses to infusion of the adenosine A1- or A2A-receptor
antagonist.
Normoxia. Infusion of vehicle for DPCPX or ZM-241385
did not significantly alter mean heart rate, MAP, or respiration,
although both infusions were associated with a small decline in
rectal temperature. The latter was likely due to the infusion of
a solution (20°C) cooler than body temperature (39.7°C).
Hypoxia. Biphasic cardiovascular changes in hypoxia in-
cluded 1) an initial rise and then fall in MAP and 2) an increase
followed by a modest retracement in mean heart rate, as
previously reported (37). Chemoreflex-mediated systemic va-
soconstriction accounted for the initial rise in arterial pressure,
whereas vasodilatation that was partly secondary to hyperven-
tilation produced the decline in MAP (9, 37). The tachycardia
resulted from stimulation evoked from several sources, includ-
ing pulmonary reflexes (via hyperpnea), aortic chemoreceptors,
central nervous system, and probably other elements (9, 37).
The carotid chemoreceptors were not directly involved because
bradycardia is the primary cardiac response to stimulation of
the carotid bodies in mammals (9).
Respiratory responses to hypoxia in both control groups
involved increased tidal volume and respiratory frequency
(decreased TTOT), which resulted in hypoxic augmentation
(phase 1) of ventilation, as reported previously (3, 7). The
magnitude of this rise in ventilation depends on input of the
peripheral arterial chemoreceptors, which increases with post-
natal age and developmental maturity, and probably also to the
extent of excitatory input from the posterior hypothalamus (3).
After 2–4 min of hypoxia, ventilation declined significantly
over the remainder of the study due to a fall in respiratory rate
and tidal volume. The mechanisms underlying this roll-off
involve a complex interaction of several factors, including
central respiratory inhibition as well as the central modulation
of excitatory afferent traffic from the carotid bodies (3). The
depressant effects of steady-state hypoxia on respiration rep-
resent a dynamic adjustment in respiratory regulation because
it can be rapidly abolished by further reductions in PaO2 (7).
Hypoxia, which increases oxygen delivery by eliciting hy-
perpnea, can also lower O2 consumption through a regulated
decrease in body temperature (2, 30). The latter would reduce
CO2 production and thus decrease excitatory input to respira-
tory drive. In the present studies, the rate of fall in rectal
temperature for vehicle-treated lambs was virtually the same
for normoxia and hypoxia, indicating that the decline during
hypoxia resulted from infusion of a room-temperature solution
rather than from a regulated lowering of metabolic rate and
core temperature in response to low PaO2. Thus hypoxia-
induced hypometabolism with a resulting fall in CO2 produc-
tion would not appear to be a major factor in the roll-off
ventilatory response to hypoxia in these lambs.
Adenosine A1-Receptor Blockade
Normoxia. DPCPX increased the lambs’ MAP results by7
mmHg, which presumably reflected increased systemic vascu-
lar resistance and/or cardiac output. These results are contrary
to our observations in unanesthetized fetal sheep in which
DPCPX did not significantly affect MAP (23, 24). In both the
fetus and newborn, mean heart rate was not altered by adeno-
sine A1-receptor blockade.
DPCPX stimulated ventilation in normoxic lambs by pri-
marily reducing inspiratory and expiratory durations. These
results, which show that adenosine A1 receptors tonically
suppress respiratory drive, are consistent with our previous
studies in unanesthetized fetal sheep (24) and in anesthetized
cats with peripheral arterial chemodenervation (36). Thus
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blockade of brain adenosine A1 receptors is the likely mecha-
nism involved in the well-recognized respiratory stimulation
evoked by nonselective adenosine receptor antagonists, such as
caffeine and theophylline. The depressant respiratory effects of
central adenosine A1-receptor activation probably involve pre-
synaptic inhibition of neurotransmitter release, postsynaptic
hyperpolarization, inhibition of intracellular cAMP production,
and activation of KATP channels (29, 36).
Hypoxia. Compared with vehicle, MAP and heart rate re-
sponses to hypoxia were qualitatively similar for DPCPX-
treated lambs. However, the posthypoxia tachycardia in the
animals with adenosine A1-receptor blockade was not observed
in vehicle-treated lambs.
Systemic blockade of adenosine A1 receptors failed to sig-
nificantly alter breathing responses to hypoxia, which counters
the notion that adenosine A1 receptors are major participants in
the second-phase decline in ventilation. The results are surpris-
ing because DPCPX administration not only antagonized cen-
tral adenosine A1 receptors that inhibit breathing but also
resulted in conditions (increased body temperature, metabolic
acidemia) that normally stimulate respiration. On the other
hand, these respiratory effects in the newborn are consistent
with our previous studies in fetal sheep in which hypoxic arrest
of breathing was not blunted by DPCPX (25).
Adenosine A1-receptor blockade by DPCPX does not alter
hypoxia-induced cerebrovasodilation (6). Thus the respiratory
effects of DPCPX appear not to be significantly affected by
drug-induced alterations in brain blood flow and O2 delivery.
In contrast to our studies in fetal sheep (25), hypoxia with
adenosine A1-receptor blockade produced a rapidly progres-
sive metabolic acidemia that restricted the duration of hypoxia
in lambs with DPCPX. At the end of hypoxia, core body
temperature in DPCPX-treated lambs was 0.33°C greater
than in vehicle-infused animals, which is consistent with an
increase in their metabolic rate. However, factors other than
increased O2 consumption are likely involved in their reduced
tolerance to hypoxia because a significant metabolic acidemia
with a decline in rectal temperature occurred in two lambs.
In four of the six lambs in which rectal temperature was
measured, DPCPX abolished the infusion-associated fall in rectal
temperature. The anterior hypothalamus, which triggers sym-
pathetic activation of brown fat metabolism (2, 27), would be
a likely site of action, although peripheral effects of adenosine
A1-receptor blockade on thermogenesis cannot be excluded.
For the two lambs in which DPCPX did not blunt the decline
in rectal temperature during hypoxia, the temperature data are
shown separately (Fig. 2A, bottom) because the results did not
represent the predominant response. In contrast to temperature,
cardiorespiratory measurements in these two animals did not
differ significantly from the group means depicted in Figs. 2A,
3A, 4, and 5A. These two lambs were studied on days of age 7
(no. 351) and 9 (no. 301), whereas the four lambs mentioned
above were 8–13 days of age. Further experiments should be
conducted to determine whether the modulation of core tem-
perature by A1 receptors changes developmentally, with inhib-
itory effects emerging 7–9 days postnatally.
Adenosine A2A-Receptor Blockade
Normoxia. ZM-41385 did not significantly affect MAP, even
though A2A-receptor blockade increased MAP by 3–5 mmHg
in near-term fetal sheep (23, 24). As in unanesthetized fetal
sheep (24), ZM-241385 did not change respiratory period or
tidal volume, which indicates that adenosine A2A receptors are
not tonically involved in respiratory regulation.
Hypoxia. ZM-241385 attenuated the rate of rise in heart rate
in newborn lambs, which suggests that peripheral and/or brain
adenosine A2A receptors modulate afferent chemoreceptor
stimuli and/or their central integration. That ZM-241385 did
not significantly alter MAP responses to hypoxia compared
with vehicle indicates that adenosine A2A receptors are not
significantly involved in this cardiovascular adaptation. This is
contrary to fetal sheep in which reflex autonomic effects of
hypoxia on systemic arterial pressure are modulated by periph-
eral adenosine A2A-receptor activity (23).
The initial hyperpnea in lambs treated with ZM-241385 was
similar to that observed for vehicle. Thus adenosine A2A
receptors associated with the peripheral arterial chemorecep-
tors or brain have little impact on the phase 1 respiratory
responses to hypoxia.
Adenosine A2A-receptor blockade abolished the roll-off re-
spiratory response to hypoxia, with the magnitude of the initial
rise in ventilation maintained throughout the entire 15 min of
hypoxia. These results differ from prior studies (10, 28, 35) in
which nonselective adenosine receptor antagonists (e.g., the-
ophylline, aminophylline, caffeine) have generally only atten-
uated the roll-off. Although peripheral effects of ZM-241385
cannot be excluded, the maintenance of ventilation for the
entire 15 min of hypoxia appears to result from antagonism of
adenosine A2A receptors in the brain, because 1) the inhibitory
influences to respiratory output in the roll-off response to
hypoxia have a central origin, 2) the maximum phase 1
stimulatory response was not significantly altered by ZM-
241385, and 3) hypoxic inhibition of breathing in the fetus is
abolished by intravascular administration of adenosine receptor
antagonists that cross the blood-brain barrier but not by those
that poorly diffuse into the brain (21, 25). This highly selective
and potent adenosine A2A-receptor antagonist may have elim-
inated the depressant phase by modulating intracellular cAMP
concentration, protein kinase activity, and calcium signaling
pathways (33).
Hypoxia increases brain adenosine concentrations, which
activate adenosine A2A receptors that modulate a number of
functions, including sleep state and motor activity (24). Thus
the findings of this study are consistent with the hypothesis that
the depressant effects of hypoxia on breathing in developing
lambs, as in the fetus (25), involve central adenosinergic path-
ways regulating behavioral adaptations to acute falls in PaO2
and possibly to other noxious stimuli, such as pain (16, 22).
Hypoxia induces a prolonged hyperventilation in conscious
adult rats, which is augmented by intracerebroventricular in-
jection of aminophylline (2). Thus central adenosine A2A
receptors likely modulate hypoxic respiratory drive, even in
mammals that do not display the biphasic response.
The respiratory effects of ZM-241385 do not appear to be
elicited by secondary effects of adenosine A2A-receptor block-
ade on brain blood flow or body temperature. First, ZM-
241385 would likely blunt hypoxia-induced vasodilatation
(and reduce brain O2 delivery) by antagonizing adenosine A2A
receptors involved in hypoxic cerebral vasodilatation. Thus
increased brain PO2 is not a likely cause of the persistence of
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peak ventilation in lambs treated with ZM-241385. Second, the
similarity in the rate of rectal temperature decline for lambs
infused with ZM-241385 and vehicle suggests that an increase
in O2 consumption (and CO2 production) was not a significant
factor in sustaining hypoxic hyperventilation in lambs with
adenosine A2A-receptor blockade.
Clinical Significance
Apnea and hypoventilation, which occur frequently in pre-
mature infants, can be associated with significant morbidity if
prolonged and associated with hypoxemia. Methylxanthines
have long been used to treat respiratory depression involving
central apnea, mixed (central and obstructive) apnea, periodic
breathing, and idiopathic apneas of prematurity. In the latter,
aminophylline has been effective in only about half of the
cases, which may be related to variable maturation in the
expression of brain stem receptors and/or intracellular trans-
duction pathways involved in respiratory control (41). The fall
in arterial O2 saturation during an apneic episode may be
another variable relevant to therapeutic success. When signif-
icant declines in arterial O2 saturation accompany apnea, the
present study indicates that a potent, highly selective antago-
nist of adenosine A2A receptors might provide better defense
against hypoxia-induced respiratory depression compared with
aminophylline or caffeine, which are comparatively weak,
nonselective adenosine receptor antagonists. DPCPX was not
effective in blunting hypoxic respiratory depression, and it
enhanced the vulnerability of the lambs to hypoxia. These
results suggest that potent highly selective antagonists of aden-
osine A1 receptors should not be used in this clinical setting
until more is known about their metabolic and cardiorespira-
tory effects in acute hypoxia.
In the conscious state, the wakefulness stimulus generally
preserves minute ventilation when accompanied by reduced
respiratory stimuli, such as hypocapnea (12). Sleep lacks this
stabilizing influence on respiratory rhythm. Besides the ab-
sence of the wakefulness drive to breathing, respiration in sleep
can be critically compromised by hypoxic inhibition and im-
paired arousal to acute falls in PaO2, which increases the
vulnerability of infants to central, obstructive, or mixed apnea
(34).
The depressant effects of hypoxia on the ventilatory roll-off
are substantially greater up to at least 5 mo of age in infants
identified as high-risk for sudden infant death syndrome
(SIDS) (17). SIDS victims, who commonly display evidence of
chronic hypoxemia, likely have elevated adenosine concentra-
tions, as described in some adults with sleep apnea disorders
(15). Thus the use of selective adenosine A2A-receptor antag-
onists has the potential to reduce the risk of SIDS in infants
with prolonged (15 s) sleep apneic episodes.
In summary, blockade of adenosine A2A receptor, which did
not affect ventilation in normoxia, abolished the depressant
effects of hypoxia on ventilation in developing lambs. Antag-
onism of adenosine A1 receptors increased ventilation in nor-
moxia but did not blunt the roll-off in hypoxia. These obser-
vations indicate that hypoxia triggers, via activation of aden-
osine A2A receptors, a crucial neuronal pathway that depresses
respiratory motoneurons.
Perspectives
Fetal breathing movements, which are episodic and inhibited
by hypoxia, would appear at first glance to have little in
common with respiration after birth. However, respiratory
stimuli and modulators generally have similar qualitative ef-
fects on breathing in both the fetus and newborn (3, 11). In the
case of adenosine receptors, the A2A (but not A1) subtype
mediates two hypoxic respiratory responses: 1) inhibition in
the fetus and 2) the phase 2 decline in the neonate. Thus fetal
breathing adaptations to hypoxia appear to persist postnatally
in the roll-off response to hypoxia. Differences in respiratory
control in the fetus (e.g., episodic apnea, hypoxic inhibition),
which generally subserve a survival role and/or a lack of
functional requirement, likely persist to a variable extent in the
newborn and contribute not only to the regulated decrease in
metabolic rate in hypoxia (30) but also to pathological disor-
ders, such as sleep apnea, hypoxic ventilatory depression, and
SIDS.
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